In this highlight of research presented at the American College of Rheumatology conference in San Diego, Dr. Cappelli discusses research related to cancer immunotherapy and inflammatory arthritis.
A new type of therapy called Immunotherapy, is used to treat cancers. It’s been observed that Immunotherapy could lead to an over-activation of the immune system. In Rheumatology we’re seeing an increase in arthritis driven by this activation of the immune system. Dr. Cappelli discusses the questions she and her oncologist colleagues have about why this happens and how do we best evaluate and treat these patients.